The active phase of LIDDS´ second phase IIa-study with Liproca® Depot has been completed successfully
The treatment of all 18 patients with localized prostate cancer in LIDDS´ second phase IIa-study with its first product Liproca® Depot has now been completed and the evaluation of the results has been initiated. A final version of the report is expected in October 2013.